> Oscient Pharmaceuticals has agreed to acquire the rights to Antara 130 mg capsules from Reliant Pharmaceuticals for $78 million. Report
> Depomed has pushed a $10 million licensing payment owed by Esprit Pharma for the antibiotic ProQuin XR back to December. Report
> Celera Genomics has received EU approval to begin marketing its diagnostic test for the Hepatitis C virus. Report
> A second Phase I trial of TorreyPines Alzheimer's therapy, NGX267, has provided fresh evidence of its safety and early signs of efficacy. Report
> France's Transgene has raised €14.3 million through the exercise of warrants. Release
> ZymoGenetics announced preliminary positive results from two Phase Ib clinical trials in patients with systemic lupus erythematosus treated with atacicept (formerly referred to as TACI-Ig). Release
And Finally… Scientists have developed two strains of rats--one vicious and the other tame--in an effort to understand the genetic keys to each. Article